Navigation Links
The effect of treatment with antibiotics and vaccination against Q fever in sheep

Scientists at Neiker-Tecnalia, the Basque Institute for Agricultural Research and Development, have evaluated the effect of treatment with antibiotics and vaccination in controlling Q fever in sheep flocks. This disease mainly causes abortions, although it can also lead to premature births, low weight and weakness in newborn lambs. The control of this disease is of great importance in animal production, as it spreads easily among the animals and causes significant economic losses, and mainly because it can be transmitted to people in contact with infected livestock.

Q fever is a zoonotic disease one that animals can transmit to humans spread all over the world and caused by the bacteria Coxiella burnetii. In animals it causes mainly reproductive problems. In people, Q fever can be asymptomatic or like a flu syndrome; however, in acute cases pneumonia and/or hepatitis can appear.

Neiker-Tecnalia's research has been focussed on sheep, since this species is one of the main reservoirs of infection in the Basque Country. The researchers found that 74% of the flocks of sheep in the Basque Autonomous Community (region) had at least one animal with Coxiella burnetii antibodies. Presence of antibodies indicates that the animal has been in contact with the bacteria, but it does not mean that it has necessarily developed Q fever. In the case of goats herds the percentage of seroprevalence was 45%; and in cattle herds, 43%.

The first method used to control Q fever in naturally infected flocks was based on the application of the antibiotic oxytetracycline. The researchers gave the antibiotic to pregnant ewes at 100 and 120 days of gestation, and abortion rate was reduced to levels lower than 4%. However, oxytetracycline did not prove to be effective in reducing the infection nor the number of bacterial shedding. So Neiker-Tecnalia is proposing that a greater research effort has to be done in this field of veterinary medicine, since there are few antibiotics authorized for sheep that are effective against intracellular bacteria like Coxiella burnetii.

Vaccination, a promising method of control

The use of an inactivated vaccine to control the disease offered more promising results. The vaccine Coxevac was used and its effectiveness was proven in the short (1 year) and long term (4 years). No immediate effects were noticed during the first year following vaccination, because the flocks studied had a high percentage of infected animals. However, with routine annual vaccinations it was possible to gradually reduce the infection until its disappearance after four years of vaccination.

The vaccine was beneficial in controlling abortions which, after the first year of vaccination, were significantly reduced (<2%). Q fever is responsible for abortion rates between approximately 6% and 10% of the ewes in an infected flock.

After four years of vaccination, the absence of the infection in the animals did not necessarily mean that the bacteria Coxiella burnetii had been eradicated on the sheep flock, since this bacterium is very persistant in the environment, and it remains present in sheep premises (surfaces, floor, aerosols) for long periods of time. So Neiker-Tecnalia recommends that after an outbreak of Q fever in a sheep flock, vaccination should be implemented for a period of five years at least. It is very important that replacement lambs are immunised against the bacterium when they reach three months of age.

Means of eliminating Coxiella burnetti

Neiker-Tecnalia scientists found that the main Coxiella burnetti shedding routes in sheep are vaginal fluids and faeces; and to a lesser extent, milk. Bacterial shedding through milk is basically concentrated in the first month after lambing, while vaginal and faecal excretion is more prolonged in time. Bacterial excretion favours the generation of contaminated aerosols and the presence of the bacteria in the air in livestock premises, so there is a risk of Q fever transmission to susceptible animals, and to people in contact with infected animals.


Contact: Irati Kortabitarte
Elhuyar Fundazioa

Related biology news :

1. Novel discovery by NUS scientists paves the way for more effective treatment of cancers
2. Lab tests show arthritis drug effective against global parasite
3. New evidence that many genes of small effect influence economic decisions and political attitudes
4. The gut could reveal effect of climate change on fish
5. WSU researchers say genes and vascular risk modify effects of aging on brain and cognition
6. Psychiatric medication effects on brain structure
7. Climatic effects of a solar minimum
8. First-of-its-kind study reveals surprising ecological effects of earthquake and tsunami
9. University of Nevada, Reno first to show transgenerational effect of antibiotics
10. Kinesiology team gets $975,000 Defense grant to study effects of heavy loads on soldiers
11. As deadly cat disease spreads nationally, MU veterinarian finds effective treatment
Post Your Comments:
(Date:11/18/2015)... New York , November 18, 2015 ... Market Research has published a new market report titled ... Growth, Trends, and Forecast, 2015 - 2021. According to the ... in 2014 and is anticipated to reach US$29.1 bn ... to 2021. North America ...
(Date:11/17/2015)... 17, 2015 Paris ... --> Paris , qui s,est ... DERMALOG, le leader de l,innovation biométrique, a inventé le ... et empreintes sur la même surface de balayage. Jusqu,ici, ... l,autre pour les empreintes digitales. Désormais, un seul scanner ...
(Date:11/17/2015)... Mass. , Nov. 17, 2015 Pressure ... leader in the development and sale of broadly enabling, ... worldwide life sciences industry, today announced it has received ... its $5 million Private Placement (the "Offering"), increasing the ... $4,025,000.  One or more additional closings are expected in ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and CEO of Neurocrine Biosciences, will be ... in New York . ... the website approximately 5 minutes prior to the presentation ... of the presentation will be available on the website ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... uBiome, were featured on AngelList early in their initial angel funding process. Now, ... syndicate for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" ... reported financial results for the quarter ended September ... in Canadian dollars and presented under International Financial ... States ," said Andrew Rae , ... regarding iCo-008 are not only value enriching for ...
(Date:11/24/2015)... -- --> --> ... Market by Product & Services (Primer, Probe, Custom Oligos, ... End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global ... expected to reach USD 1,918.6 Million by 2020 from ... 10.1% during the forecast period. Browse 183 ...
Breaking Biology Technology: